BPC 157 has been extensively studied in various clinical trials for its regenerative effects on various bodily tissues, including muscles, tendons, ligaments, and the gastrointestinal tract and may modulate vascular endothelial growth factor (VEGF) expression, promoting healing by enhancing the formation and growth factor of new blood vessels
Imaging studies offer the most objective assessment but add cost and complexity
PMC Early clinical safety work: Phase 1/2 investigations with T4 examined IV/topical use and general tolerability, but did not establish approved indications
Other tests may help to diagnose PA, such as the presence of an atrophic gastritis and autoantibodies towards notably intrinsic factor, but we lack routine procedures that can fully replace the Schillings Tests
MOTS-C has been shown to reverse these age-related metabolic changes by improving insulin sensitivity and promoting cellular energy production
What isn't well established, at least in published human research, is exactly how much intact BPC-157 an oral dose delivers relative to an injected one, or whether a given oral mcg amount and a given injected mcg amount produce comparable results
